- Home
- VS vs HOOK Comparison
VS vs HOOK Comparison
Compare VS & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VS
- HOOK
- Stock Information
- Founded
- VS 2013
- HOOK 2011
- Country
- VS United States
- HOOK United States
- Employees
- VS N/A
- HOOK N/A
- Industry
- VS EDP Services
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- VS Technology
- HOOK Health Care
- Exchange
- VS Nasdaq
- HOOK Nasdaq
- Market Cap
- VS 10.1M
- HOOK 9.3M
- IPO Year
- VS N/A
- HOOK 2019
- Fundamental
- Price
- VS $2.27
- HOOK $1.56
- Analyst Decision
- VS Hold
- HOOK Buy
- Analyst Count
- VS 1
- HOOK 4
- Target Price
- VS $2.00
- HOOK $10.67
- AVG Volume (30 Days)
- VS 22.8K
- HOOK 166.9K
- Earning Date
- VS 05-15-2025
- HOOK 06-17-2025
- Dividend Yield
- VS N/A
- HOOK N/A
- EPS Growth
- VS N/A
- HOOK N/A
- EPS
- VS N/A
- HOOK N/A
- Revenue
- VS $230,132.00
- HOOK $9,351,000.00
- Revenue This Year
- VS $3,459.21
- HOOK N/A
- Revenue Next Year
- VS N/A
- HOOK N/A
- P/E Ratio
- VS N/A
- HOOK N/A
- Revenue Growth
- VS 64.71
- HOOK N/A
- 52 Week Low
- VS $1.00
- HOOK $0.72
- 52 Week High
- VS $9.59
- HOOK $8.50
- Technical
- Relative Strength Index (RSI)
- VS 64.03
- HOOK 56.94
- Support Level
- VS $2.01
- HOOK $1.51
- Resistance Level
- VS $2.10
- HOOK $1.65
- Average True Range (ATR)
- VS 0.10
- HOOK 0.14
- MACD
- VS 0.02
- HOOK -0.02
- Stochastic Oscillator
- VS 81.84
- HOOK 34.37
About VS Versus Systems Inc.
Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.